DOE awards $377 million in funding for 46 energy frontier research centers
... solid-state lighting, and conversion of heat into
Columbia University (New York, ... in the efficient conversion of
electricity in nanometer sized thin films.
... of the complex molecules
comprising biomass into
chemicals and fuels.
Massachusetts Institute ...
Novavax Reports Second Quarter 2009 Financial Results
... 100% of its convertible debt, and entered into
an initial agreement with ROVI Pharmaceuticals of ... plus accrued and unpaid interest.
an initial agreement to license the company's ... agreements; the Company's ability to enter into
future collaborations with industry partners and ...
NeurogesX Reports Second Quarter 2009 Results
... Europe we significantly advanced our progression into
a commercial company while finalizing our ... and other product candidates; plans for entry into
a U.S. commercialization partnership, including the timing with respect to entry into
such a partnership; strategies to obtain ...
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
... He will focus on bringing this concept forward into
clinic trials and expanding the indications ... have the knowledge and tools to turn this concept into
a clinical reality."
Dr Karen Newell and ... is completing negotiations to convert the option into
an exclusive worldwide license covering a broad ...
Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
... needs today announced that they
have entered into
a worldwide, exclusive license agreement for ...
"We are very pleased to have entered into
this license agreement with
Debiopharm. We have ... payments will
extend our cash runway well into
"We expect additional data during ...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
... manufacturers who assemble those components into
finished medical devices. Sales of our Base ... driven primarily by the entry of new competitors into
the drug-eluting coronary stent market during the ... In June 2009, we announced that we had entered into
license, distribution, development and supply ...
AIAG and MichBio Form New Collaborative Partnership
... Automotive Manufacturing Base Diversify into
Medical Device Manufacturing
... lost from the automotive industry and diversify into
the exploding medical devices market. While the ... industry which can be readily transition into
other manufacturing industries.
"We are ...
Plastics that convert light to electricity could have a big impact
... least 10 percent of the sunlight that they absorb into
usable electricity and can be easily ... of exactly how a solar cell converts light into
electricity. Ginger believes that will lead to a ... nanostructured plastic solar cells could be put into
use on a broad scale, he said. As a start, they ...
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
... compared to sucralose alone when incorporated into
a flavor system. Senomyx and Firmenich entered into
a collaboration in November 2008 under which ... will be issued a pin number to use when dialing into
the live call, which will provide quick access to ...
SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS
... company, announced today that they have entered into
a collaborative research, development, ... Senomyx to have our Sweet Enhancers introduced into
the marketplace as quickly, broadly and ... bitter, and cooling areas. Senomyx has entered into
product discovery and development collaborations ...
Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
... Inc. (Nasdaq: TSPT ) today announced entry into
an exclusive license and collaboration agreement ... towards the launch of this potential new entry into
the prescription sleep aid market. This agreement ... portfolio and broaden our commercial focus into
therapeutic areas that complement our leadership ...
Model predicts evolution of Mediterranean landscape following fires
... according to the variables introduced. It takes into
consideration parameters such as the dispersal of ... a lack of Holm oak acorns, a burned area can turn into
a pine forest within 30 years. However, in good ... and soil conditions, the ecosystem could develop into
a deciduous chestnut and melojo oak forest.
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
... cardiovascular and wound healing biologics, into
the emerging new high growth market segment of ... have shown that proliferative cells migrate into
the Gene Activated Matrix and then take up the ... short half-life of a protein once administered into
the human body, the Company believes that the ...
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
... our targeted areas of future growth by entering into
a collaborative agreement with Biocon in the area ... a government-mandated price reduction, which went into
effect in July 2008, were more than offset by ... revenue and gross profit despite the entrance into
the market of additional generic competition. ...
NIST scientists study how to stack the deck for organic solar power
... molecules to capture sunlight and convert it into
electricity, are a hot research area because in ... convert less than 6 percent of light into
electricity and last only a few thousand hours. ... ink is applied to a surface, the blend hardens into
a film that contains a haphazard network of ...
Sanofi-aventis Announces Second Quarter 2009 Results
... line with the request of CHMP. These actions take into
account the recommendations recently made by an ... Oncology (ASCO), and the product has since moved into
Phase III. A license agreement has been signed ... of malignant tumors. We have also entered into
a collaboration agreement with Kyowa Kirin.
United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients
... Utilizing a needle-tipped catheter inserted into
the groin of a patient who is suffering from heart failure, the cells are injected into
the scar tissue that has formed in the patient's ... to transition this second-generation product into
its FDA-authorized Phase II/III MARVEL study. ...
Charging ahead: University of Houston team revealing secrets of electricity-producing materials
... Piezoelectric materials convert mechanical energy into
electrical energy, Sharma explains.
"Indeed, ... amount of energy," he says, and could be made into
electricity by piezoelectric nanostructures in ... plenty of waste energy that can be harnessed into
useful energy to make ours a "self-powered ...
GreenHouse Debuts the World's First E-Fuel MicroFuelerTM in Los Angeles
... micro-refinery system that turns organic waste into
a high performance ethanol fuel for cars. The ...
The E-Fuel MicroFueler converts organic waste into
ethanol for about two-thirds the cost of ... unit both produces ethanol and pumps it into
your car directly from your residence. The ...
PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
... Inc., today announced that it has entered into
stock purchase agreements with private investors ... the board and management to help build PROLOR into
a significant player in the therapeutic proteins ... including the shares of PROLOR's common stock into
which the preferred shares may be converted, have ...
Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International
... stem (iPS) cells to reproducibly differentiate into
essential cell types for drug discovery and ... skin cells without the integration of foreign DNA into
the genome. This non-integrating methodology, ... and removes the barrier of taking the technology into
a clinical setting. (See illustration, iPS 2.0: ...
Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government
... is being developed under a contract entered into
in 2006 with the Biomedical Advanced Research and ... that anthrax spores can be aerosolized and turned into
a bioterrorist weapon with the potential to cause ... toxins after they are released by the bacteria into
the blood and tissues. In an inhalation anthrax ...
Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors
... additional capital we raised will help us grow into
our key target segments," said Dr. Neil Bartlett, ... Australian Stock Exchange and the Wallis Inquiry into
the Financial System.
Des Masters has ... in Adelaide, Australia in 2005 and expanded into
the U.S. in 2008, dedicated to developing fast ...
$10,000 ISSAC Award for Innovation Presented to MIT PhD
... of implantable medical devices that release drugs into
the body in a controlled manner. Combination ... a pump, using osmotic pressure to release drugs into
the bladder. The size of the device, which is ... the system is designed to deliver drugs into
the bladder for a specific period of time. The ...
Heart disease: Research off the beating patch
... to introduce living, healthy heart muscle cells into
damaged areas of the heart in a way that is much ... practiced method of injecting cells into
heart tissue," says study leader Steven Goldman, ... cells with no supporting structure are injected into
heart tissue, Goldman's group uses a patch ...
NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
... medical need, announced today it has entered into
an advisory consulting agreement with Dr. Cai ... to assist the company with its expansion into
China and facilitate collaborations with ... future medical need. The Company has also entered into
research and development through the acquisition ...
UCSF researchers help crack parasite genome, identify drug leads
... of approved drugs that may quickly translate into
therapies to combat the disease.
The work ... those eggs must be evacuated in urine or feces into
fresh water, where the next parasitic stage seeks ... the track record of the Sandler Center's research into
the biology and therapeutic potential of parasite ...
Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing
... As the stem cells begin to differentiate into
different terminal cell types (e.g. heart, blood, ... While cardiomyocytes are the company's entree into
the market, the company has programs in place for ... Field patents enable the company to develop them into
highly purified populations. CDI is using the ...
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
By the end of 2008 Santaris Pharma entered into
an agreement with Wyeth
Pharmaceuticals, covering ... may be necessary to copy and paste
this hyperlink into
your Internet browser's URL address field. Remove ... may be necessary to copy and paste
this hyperlink into
your Internet browser's URL address field. Remove ...
ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens
... (IVT), a vaccine development company, has entered into
an agreement to exclusively license seven cancer ... six months the company will fast-track DPX-0907 into
Phase 1 clinical trials.
"Advanced-stage ... the value of Depovax(TM) has been brought into
the limelight. www.immunovaccine.com .
Politicians to Drive on Straw-Based Bioethanol at the Climate Change Conference
... its technology for converting straw into
bioethanol, will produce the new fuel at its ... soft cellulosic biomass like wheat straw into
ethanol. Since 2003 Inbicon has been developing ... in Kalundborg. The plant will convert wheat straw into
ethanol and other green products; it will open in ...
Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae
... long-term research and development exploration into
the most efficient and cost effective organisms ... energy from sunlight to convert carbon dioxide into
cellular oils (lipids) and even some types of long-chain hydrocarbons that can be further processed into
fuels and chemicals. However, naturally-occurring ...
New drugs faster from natural compounds: A UC San Diego breakthrough
... timeline for bringing new experimental therapies into
clinical application," said William Gerwick, an ... mass spectrometers that break the cyclic peptides into
smaller and smaller linear pieces.
First, the ... that can accomplish this and is a glimpse into
the future of modern drug discovery."
New method may accelerate drug discovery for difficult diseases like Parkinson's
... Most current drugs act by wedging themselves into
small pockets on the surfaces of target proteins. ... He then inserted the cyclic peptides into
cells of a well-established yeast model of ...
Once the cyclic peptides were inserted into
the model yeast cells, Kritzer switched the ...
Stem cells' 'suspended' state preserved by key step, scientists report
... to efficiently reprogram mature cells back into
the pluripotent state, an elusive step in stem ... process -- converting specialized cells back into
the all-purpose stem cell stage is another great ... cells to produce healthy neurons to introduce into
The new research, conducted on mouse ...
iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
... to translate our stem cell research efforts into
therapeutic realities for patients. Our initial ... be in neurodegenerative disease and longer term into
metabolic and cardiovascular diseases, as well as ... experience in translating promising science into
Dr. Deepak ...
New Report Just Published: World Prostate Cancer Therapeutics Market Report
... Research Partnership II-68
Celera Enters into
Licensing Agreement with Merck II-69
Celera ... MGI Pharma II-70
BN ImmunoTherapeutics Enters into
a Scientific Partnership
with NCI II-70
Morphotek(R) Enters into
Licensing Agreement with NCI II-71
Verenium Completes Amendment to 8% Senior Convertible Notes
... Notes due April 1, 2012 (the "Notes") entered into
and announced on July 1, 2009 is effective as of 8:00 a.m. today. The Company has entered into
Convertible Note Amendment Agreements with ... with our partner BP has been selected to enter into
the due diligence phase of the DOE Loan Guarantee ...
NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State
... Redeemable Preferred Stock, convertible into
ten shares of common stock and ten warrants each ... Preferred Sock will automatically convert into
ten shares of Common Stock.
Dr. Robin ... medical need. The Company also has entered into
research and development through the acquisition ...
Stanford researchers find a quicker, cheaper way to sort isotopes
... collaborators have created burns chemical samples into
a gas, which then flows through a laser beam that ... is fully developed and commercialized, "It'll fit into
the backseat of a car," Zare said. This portability can take isotopic analysis directly into
the field, whether it's a doctor's office or a ...